Skip to content
Annika Bansal – Lifestyle
Author:
Dyne Therapeutics, Inc.
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
March 8, 2026
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
March 8, 2026
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 5, 2026
Dyne Therapeutics to Participate in Upcoming Investor Conferences
March 4, 2026
←
Previous Page
1
2
3